Tuesday, October 22, 2019
Home Healthcare

Healthcare

Healthcare Companies

Building Healthy Portfolios: Post Mid-Term Madness Portfolio Strategies

Finally, it’s over! The mid-terms have come and gone, and the winners and losers will be debating who actually won and lost for a... Read more
Value Investing

Forget FAANG Start Investing in Value Stocks

Over the past several years, investors in growth stocks have been handsomely rewarded, compared to their peers who have largely favored value stocks. Typically... Read more
Short Selling Stocks

3 Top Short Ideas – Investing With The Gurus

Short-selling, the act of buying a stock high and betting that its price will take a dive in the future, isn’t every investor’s cup... Read more
Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson ($JNJ): An Undervalued Stock with Huge Growth Potential

Johnson & Johnson (NYSE: JNJ) is the biggest healthcare company in the U.S in terms of market value. But the stock has been losing... Read more
Cardinal Health Inc. (NYSE:CAH)

Cardinal Health (CAH) – a Dividend Aristocrat Set to Rebound or...

The dividend aristocrats, a group of high quality companies, has rewarded shareholders with safe and reliable income for many years. However, sometimes, a company... Read more
Penny Stocks

Penny Stocks: Investing in the China Story May Be Worth More...

Penny Stocks are very sensitive to the day’s headlines. That’s why many Penny Stock holders are speculators, preferring to buy the rumor and sell... Read more
Healthcare stocks

Why Medtronic PLC (NYSE:MDT) Is a Strong Buy?

Medtronic is one of those companies you don’t need a reason for buying. You need a reason for not buying it. With a proven... Read more
Johnson & Johnson (NYSE:JNJ)

Here’s Why Johnson & Johnson (NYSE:JNJ) Is a Buy

Johnson & Johnson (NYSE: JNJ) is in the news after the company said its CFO will step down. Irrespective of the executive changes, let’s... Read more
Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (GILD) Blockbuster Pipeline, M&A to Offset HCV Declines

2017 was not a good year for Gilead Sciences, Inc. (NASDAQ:GILD), as the company announced weak sales of core hepatitis C drugs Harvoni, Sovaldi... Read more
Healthcare Companies

Will Berkshire Hathaway, JPMorgan and Amazon Succeed in Disrupting the Healthcare...

The latest rumour has it that Warren Buffet, Jeff Bezos and Jamie Dimon will team up to disrupt the healthcare sector. They say that... Read more